Join us today for our presentation at the RBC Capital Markets Global Healthcare Conference. Tune in to the live webcast at 3:35 pm ET. investors.edgewisetx.com/events-and-pre…

Healthcare for people living with Becker muscular dystrophy is best managed through routine and coordinated checkups with different specialists, including cardiologists, neurologists, physical therapists, and primary care physicians. Learn more: beckermusculardystrophy.com

We look forward to presenting at the RBC Capital Markets Global Healthcare Conference. Tune in to the live webcast on Wednesday, May 15 at 3:35 pm ET.
investors.edgewisetx.com/events-and-pre…

Today we announced Q1 2024 financial results and recent business highlights. The results are available on our website: investors.edgewisetx.com/financials/qua…

We’re heading to Spain for Duchenne Parent Project España International Congress. This provides a great opportunity to stay up to date with current scientific advances as well as the improvement of standards of care in #Duchenne & #Becker #musculardystrophy .duchenne-spain.org/blog/congreso-…

Join us on Monday, May 13 for a Community Webinar hosted by Muscular Dystrophy Association where we will provide a the latest updates on our Becker muscular dystrophy program.
Register here: zoom.us/webinar/regist…

This morning we announced the initial dosing of EDG-7500 in CIRRUS, a Phase 2 trial in individuals with hypertrophic cardiomyopathy. Learn more: investors.edgewisetx.com/news/news-deta…

We will report our Q1 2024 financial results and recent business highlights on Thursday, May 9 before-market open. The results will be available on our website here:
investors.edgewisetx.com/financials/qua…

Let’s cheer on Nicole from our Edgewise team who is riding the Five Boro Bike Tour in NYC on May 5 to raise money for Parent Project Muscular Dystrophy (PPMD). Consider supporting her ride today:
donate.parentprojectmd.org/fundraiser/540…

We are proud to support the TheAkariFoundation and their workshop fully in Spanish for families with Duchenne muscular dystrophy this Saturday, April 27 in Ponce, Puerto Rico. We hope to see you there!
theakarifoundation.org

Mark Your Calendar! Join the 2024 Becker Education and Engagement Day on Saturday, Sept. 28 at 6 US locations: California, Florida, Missouri, Pennsylvania, Texas and Washington. BEED is a day to bring education and connection to the #Becker community. beckereducationandengagement.com

Today we announced that the European Medicines Agency has granted Orphan Drug Designation for sevasemten (EDG-5506) for the treatment of Becker muscular dystrophy and for the treatment of Duchenne muscular dystrophy. Check out our press release:
investors.edgewisetx.com/news/default.a…

We are proud to be a Gold sponsor of the International Congress of Myology International Congress in Paris this week. Stop by our booth #11 to learn more about our trials in #Duchenne and #Becker #musculardystrophy .
myology2024.org

GRAND CANYON, a pivotal clinical study to evaluate an investigational drug in individuals living with #Becker #musculardystrophy is ongoing. Visit the study website to learn more. beckergcstudy.com

We’re heading to Cincinnati, OH this week for Parent Project Muscular Dystrophy (PPMD) Together which is about coming together, sharing experiences and shaping a future where every individual affected by #Duchenne and #Becker can thrive. donate.parentprojectmd.org/event/ppmd-tog…

We’re presenting updated ARCH data in Becker muscular dystrophy at American Academy of Neurology today. We value connecting with attendees and sharing information about our ongoing efforts in #Becker & #Duchenne #musculardystrophy . The presentation is on our website: edgewisetx.com/science/poster…

Today we announced positive two-year topline data from the ARCH open label study of sevasemten (EDG-5506) in individuals with Becker muscular dystrophy. See our press release to learn more. investors.edgewisetx.com/news/default.a…

We are proud to be featured in Money Movers today as part of their coverage on the booming life science community in Colorado.

Our Carl Quintanilla saw everything as far as you can see in Colorado⛰️

He joins us to preview 'Cities of Success: Denver & Boulder' with a look at the region's exploding life sciences industry🧪

🚨 Catch the full special TONIGHT at 10p ET, only on CNBC 🚨

We’re excited to introduce Beck, a 13-year-old who loves driving his side-by-side on trails & has fun playing soccer on a power wheelchair team, where his competitive spirit shines through. Read more about Beck & his experiences of living with Duchenne. edgewisetx.com/patients-famil…